Interaction of hedgehog and vitamin D signaling pathways in basal cell carcinomas

Advances in Experimental Medicine and Biology

Volumn 810, Issue , 2014, Pages 329-341

  Albert, Benedikt ^a   Hahn, Heidi ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; COLECALCIFEROL; CYCLOPAMINE; OXYGENASE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SONIC HEDGEHOG PROTEIN; VISMODEGIB; VITAMIN D; VITAMIN D RECEPTOR; 1,25-DIHYDROXYVITAMIN D; CALCITRIOL RECEPTOR; CELL SURFACE RECEPTOR; DRUG DERIVATIVE; G PROTEIN COUPLED RECEPTOR; PATCHED RECEPTORS; SMO PROTEIN, HUMAN;

APOPTOSIS; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; BINDING AFFINITY; BINDING SITE; BIOSYNTHESIS; CARCINOGENESIS; CATABOLISM; CELL CYCLE REGULATION; CELL PROLIFERATION; CILIUM; DISEASE PREDISPOSITION; DISSOCIATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEEDBACK SYSTEM; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; HOMEOSTASIS; HUMAN; KERATINOCYTE; LIGAND BINDING; MOLECULAR GENETICS; NIEMANN PICK DISEASE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; PTCH GENE; QUALITY OF LIFE; SIGNAL TRANSDUCTION; STEROL METABOLISM; TRANSCRIPTION REGULATION; TRANSLATION INITIATION; TUMOR SUPPRESSOR GENE; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; MUTATION; PATHOLOGY; REVIEW; SKIN; SKIN TUMOR; ULTRAVIOLET RADIATION;

ANIMALS; CARCINOMA, BASAL CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEDGEHOG PROTEINS; HUMANS; MICE; MUTATION; RECEPTORS, CALCITRIOL; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; ULTRAVIOLET RAYS; VITAMIN D;

EID: 84907169752     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: None     Document Type: Chapter

References (68)

1. Nüsslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 1980; 287:795-801. PMID:6776413; http://dx.doi.org/10.l038/287795a0
2. Hooper JE, Scott MP. Communicating with Hedgehogs. Nat Rev Mol Cell Bioi 2005; 6:306-17. PMID:15803137; http://dx.doi.org/10.1038/nrml622
3. Varjosalo M, Taipale J. Hedgehog signaling. J Cell Sci 2007; 120:3-6. PMID:l7182898; http://dx.doi.org/10.1242/jcs.03309
4. Varjosalo M, Taipale J. Hedgehog: functions and mechanisms. Genes Dev 2008; 22:2454-72. PMID: 18794343; http://dx.doi.org/10.110./gad.l693608
5. McMahon AP, Ingham PW, Tabin CJ. Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol 2003; 53:1-114. PMID: 12509125; http:l/dx.doi.org/10.1016/S0070-2153(03)53002-2
6. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432:324-31. PMID: 15549094; http://dx.doi.org/10.1038/nature03100
7. Ruizi Altaba A Hedgehog signaling and the Gli code in stem cells, cancer, and metastases. Sci Signal 2011; 4.PMID:22114144; http://dx.doi.org/10.1126/scisignal.2002540
8. Ruizi Altaba A, Mas C, Stecca B. The Gli code: an information nexus regulating cell fate, sternness and cancer. Trends Cell Biol 2007; 17:438-47. PMID:17845852; http://dx.doi.org/10.1016/j.tcb.2007.06.007
9. Huangfu D, Anderson KV. Signaling from Smo to Ci/Gli: conservation and divergence of Hedgehog pathways from Drosophila to vertebrates. Development 2006; 133:3-14. PMID: 16339192; http://dx.doi. org/10.1242/dev.02169
10. Rohatgi R, Scott MP. Patching the gaps in Hedgehog signalling. Nat Cell Biol2007; 9:1005-9. PMID: 17762891; http://dx.doi.org/10.1038/ncb435
11. Cohen MM Jr.. Hedgehog signaling update. Am J Med Genet A 2010; 152A:1875-914. PMID:20635334; http://dx.doi.org/10.1002/ajmg.a.32909
12. Aberger F, Kern D, Greil R, Hartmarm TN. Canonical and noncanonical Hedgehog/GLI signaling in hematological malignancies. Vitam Horm 2012; 88:25-54. PMID:22391298; http://dx.doi.org/10.1016/B978-0-12-394622-5.00002-X
13. Scales SJ, de Sauvage FJ. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci 2009; 30:303-12. PMID: 19443052; http://dx.doi.org/10.1016/j.tips.2009.03.007
14. Cooper MK, Porter JA, Young KE, Beachy PA Teratogen-mediated inhibition oftargettissue response to Shh signaling. Science 1998; 280: 1603-7. PMID:9616123; http://dx.doi.org/10.1126/science.280.5369.1603
15. Chen JK, Taipale J, Cooper MK, Beachy PA Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 2002; 16:2743-8. PMID:12414725; http://dx.doi.org/10.11011gad.l025302
16. Gorlin RJ. Nevoid basal-cell carcinomasyndrome. Medicine (Baltimore) 1987;66:98-113. PMID:3547011; http://dx.doi.org/10.1097/00005792-198703000-00002
17. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996; 272:1668-71. PMID:8658145; http://dx.doi.org/10.1126/science.272.5268.1668
18. Hahn H, Christiansen J, Wicking C, Zaphiropoulos PO, Chidambaram A, Gerrard B, et al. A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities. JBiol Chern 1996;271:12125-8. PMID:8647801; http://dx.doi.org/10.1074/jbc.271.21.12125
19. Dahmane N, Lee J, Robins P, Heller P, Ruiz i Altaba A. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 1997; 389:876-81. PMID:9349822; http://dx.doi.org/10.1038/39918
20. Gailani MR, Ståhle-Bäckdahl M, Leffell DJ, Glynn M, Zaphiropoulos PO, Pressman C, et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. [see comments]. Nat Genet 1996; 14:78-81. PMID:8782823; http://dx.doi.org/10.1038/ng0996-78
21. Aszterbaum M, Rothman A, Johnson RL, Fisher M, Xie J, Bonifas JM, et al. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol1998; 110:885-8. PMID:9620294; http://dx.doi.org/10.1046/j.1523-1747.1998.00222.x
22. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, et al. Activating Smoothened mutations in sporadic basal-cell carcinoma Nature 1998; 391:90-2. PMID:9422511; http://dx.doi.org/10.1038/34201
23. Reifenberger J, Wolter M, Weber RG, Megahed M, Ruzicka T, Lichter P, et al. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1998; 58:1798-803. PMID:9581815
24. Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008; 8:743-54. PMID: 18813320; http://dx.doi.org/10.1038/nrc2503
25. Von Hoff DD, Lo Russo PM, Rudin CM, Reddy JC, Yauch RL, Tibes R, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009; 361:1164-72. PMID:l9726763; http://dx.doi.org/10.1056/NEJMoa0905360
26. Athar M, Tang X, Lee JL, Kopelovich L, Kim AL. Hedgehog signalling in skin development and cancer. Exp Dermatol 2006; 15:667-77. PMID:16881963; http://dx.doi.org/10.1111/j.1600-0625.2006.00473.x
27. Adolphe C, Hetherington R, Ellis T, Wainwright B. Patchedl functions as a gatekeeper by promoting cell cycle progression. Cancer Res 2006; 66:2081-8. PMID:16489008; http:/1dx.doi.org/10.1158/0008-5472.CAN-05-2146
28. Mancuso M, Pazzaglia S, Tanori M, Hahn H, Merola P, Rebessi S, et al. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptchl-deficient mice. Cancer Res 2004; 64:934-41. PMID:l4871823; http://dx.doi.org/10.1158/0008-5472.CAN-03-2460
29. Oro AE, Higgins KM, Hu Z, Bonifas JM, Epstein EH Jr., Scott MP. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science 1997; 276:817-21. PMID:9115210; http://dx.doi.org/10.1126/science.276.5313.817
30. Yang SH, Andl T, Grachtchouk V, Wang A, Liu J, Syu LJ, et al. Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wntlbeta3-catenin signaling. Nat Genet 2008; 40:1130-5. PMID:19165927; http://dx.doi.org/10.1038/ng.l92
31. Nilsson M, Undén AB, Krause D, Malmqwist U, Raza K, Zaphiropoulos PG, et al. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. [In Process Citation]. Proc Natl Acad Sci USA 2000; 97:3438-43. PMID:10725363; http://dx.doi.org/10.1073/pnas.97.7.3438
32. Grachtchouk M, Mo R, Yu S, Zhang X, Sasaki H, Hui CC, et al. Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat Genet 2000; 24:216-7. PMID:10700170; http://dx.doi.org/10.1038/73417
33. Hutchin ME, Kariapper MS, Grachtchouk M, Wang A, Wei L, Cummings D, et al. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev 2005; 19:214-23. PMID:l5625189; http://dx.doi.org/10.1101/gad.1258705
34. Grachtchouk V, Grachtchouk M, Lowe L, Johnson T, Wei L, Wang A, et al. The magnitude of hedgehog signaling activity defines skin tumor phenotype. EMBO J 2003; 22:2741-51. PMID:12773389; http://dx.doi.org/10.1093/emboj/cdg271
35. Nitzki F, Becker M, Frommhold A, Schutz-Schaeffer W, Halm H. Patched knockout mouse models of Basal cell carcinoma. JSkin Cancer 2012;2012:907543. PMID:23024864;;http://dx.doi.org/10.1155/2012/907543.
36. Chen JK, Taipale J, Young KE, Maiti T, Beachy PA. Small molecule modulation of Smoothened activity. Proc Natl Acad Sci USA 2002; 99:14071-6. PMID:12391318; http://dx.doi.org/10.1073/pnas.182542899
37. Tremblay MR, Nevalainen M, Nair SJ, Porter JR, Castro AC, Behnke ML, et al. Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists. J Med Chern 2008; 51:6646-9. PMID: 18842035; http://dx.doi.org/10.1021/jm8008508
38. Rudin CM. Vismodegib. Clin Cancer Res 2012; 18:3218-22. PMID:22679179;http://dx.doi.org/10.1158/1078-0432.CCR-12-0568
39. Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ. Vitamin D: metabolism. [table of contents.]. Endocrinol Metab Clin North Am 2010; 39:243-53. PMID:20511049; http://dx.doi.org/10.1016/j.ecl.2010.02.002
40. Zehnder D, Bland R, Williams MC, Mc Ninch RW, Howie AJ, Stewart PM, et al. Extrarenal expression of 25-hydroxyvitamind(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86:888-94. PMID: 11158062; http://dx.doi.org/10.1210/jc.86.2.888
41. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007; 7:684-700. PMID: 17721433; http://dx.doi.org/10.1038/nrc2196
42. Costa EM, Feldman D. Measurement of 1,25-dihydroxyvitamin D3 receptor turnover by dense amino acid labeling: changes during receptor up-regulation by vitamin D metabolites. Endocrinology 1987; 120:1173-8. PMID:3026787; http://dx.doi.org/10.1210/endo-120-3-1173
43. Wiese RJ, Uhland-Smith A, Ross TK, Prahl JM, De Luca HF. Up-regulation of the vitamin D receptor in response to 1,25-dihydroxyvitamin D3 results from ligand-induced stabilization. J Bioi Chern 1992; 267:20082-6. PMID:1328192
44. Trump DL, Deeb KK, Johnson CS. Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer J 2010; 16:1-9. PMID:20164683; http://dx.doi.org/10.1097/PPO.Ob013e3181c51ee6
45. Bikle DD (2012) Protective actions of vitamin D in UVB induced skin cancer. Photochemical & photobiological sciences: Official journal of the European Photochemistry Association and the European Society for Photobiology 11: 1808-16.
46. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980; 9:227-31. PMID:7440046; http://dx.doi.org/10.1093/ije/9.3.227
47. Majewski S, Skopinska M, Bollag W, Jablonska S. Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions. Lancet 1994;344:1510-1. PMID:7968149; http://dx.doi.org/10.1016/S0140-6736(94)90330-1
48. Mitschele T, Diesel B, Friedrich M, Meineke V, Maas RM, Gärtner BC, et al. Analysis of the vitamin D system in basal cell carcinomas (BCCs). Lab Invest 2004; 84:693-702. PMID:15077124; http://dx.doi. org/1 0.1038/1abinvest.3700096
49. Lesiak A, Norval M, Wodz-Naskiewicz K, Pawliczak R, Rogowski-Tylman M, Sysa-Jedrzejowska A, et al. An enhanced risk of basal cell carcinoma is associated with particular polymorphisms in the VDR and MTHFR genes. Exp Dermato1 2011; 20:800-4. PMID:21732987; http://dx.doi.org/10.1111/j.1600-0625.201l.01328.x
50. Köstner K, Denzer N, Koreng M, Reichrath S, Graber S, Klein R, et al. Association of genetic variants of the vitamin D receptor (VDR) with cutaneous squamous cell carcinomas (SCC) and basal cell carcinomas (BCC): a pilot study in a German population. Anticancer Res 2012; 32:327-33. PMID:22213323
51. Zinser GM, Sundberg JP, Welsh J. Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis 2002; 23:2103-9. PMID:12507934; http://dx.doi.org/10.1093/carcin/23.12.2103
52. Teichert AE, Elalieh H, Elias PM, Welsh J, Bikle DD. Overexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null mice. J Invest Dermatol 2011; 131:2289-97. PMID:21814234; http://dx.doi.org/10.1038/jid.2011.196
53. Tseng TT, Gratwick KS, Kollman J, Park D, Nies DH, Goffeau A, et al. The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins. J Mol Microbiol Biotechnol 1999; 1:107-25. PMID:10941792
54. Taipale J, Cooper MK, Maiti T, Beachy PA. Patched acts catalytically to suppress the activity of Smoothened. Nature 2002; 418:892-7. PMID:12192414; http://dx.doi.org/10.1038/nature00989
55. Davies JP, Chen FW, Ioannou YA. Transmembrane molecular pump activity of Niemarm-Pick C I protein. Science 2000; 290:2295-8. PMID: 11125140; http://dx.doi.org/10.1126/science.290.5500.2295
56. Kuwahara PE, Labouesse M. The sterol-sensing domain: multiple families, a unique role? Trends Genet 2002; 18:193-201. PMID: 11932020; http://dx.doi.org/10.1 016/S0168-9525(02)02640-9
57. Bijlsma MF, Spek CA, Peppelenbosch MP. Hedgehog: an unusual signal transducer. Bioessays 2004; 26:387-94. PMID:15057936; http://dx.doi.org/10.1 002/bies.20007
58. Bidet M, Joubert O, Lacombe B, Ciantar M, Nehmé R, Mollat P, et al. The hedgehog receptor patched is involved in cholesterol transport. PLo S ONE 2011; 6:e23834. PMID:21931618; http://dx.doi.org/10.13711joumal.pone.0023834
59. Corcoran RB, Scott MP. Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells. Proc Natl Acad Sci USA 2006; 103:8408-13. PMID:l6707575; http://dx.doi.org/10.1073/pnas.0602852103
60. Dwyer JR, Sever N, Carlson M, Nelson SF, Beachy PA, Parhami F. Oxysterols are novel activators of the hedgehog signaling pathway in pluripotent mesenchymal cells. J Bioi Chern 2007; 282:8959-68. PMID: 17200122; http://dx.doi.org/10.1074/jbc.M611741200
61. Rohatgi R, Milenkovic L, Scott MP. Patchedl regulates hedgehog signaling at the primary cilium. Science 2007; 317:372-6. PMID: 17641202; http://dx.doi.org/10.1126/science.1139740
62. Nachtergaele S, Mydock LK, Krishnan K, Rammohan J, Schlesinger PH, Covey DF, et al. Oxysterols are allosteric activators of the oncoprotein Smoothened. Nat Chern Biol 2012; 8:211-20. PMID:22231273; http://dx.doi.org/10.1038/nchembio.765
63. Bijlsma MF, Spek CA, Zivkovic D, van de Water S, Rezaee F, Peppelenbosch MP. Repression of smoothened by patched-dependent (pro-)vitamin 03 secretion. PLo S Bioi 2006; 4:e232. PMID:16895439; http://dx.doi.org/10.1371/joumal.pbio.0040232
64. Uhmarm A, Niemann H, Lanunering B, Henkel C, Hess I, Nitzki F, et al. Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation. Mol Cancer Ther 2011; 10:2179-88. PMID:21878656; http://dx.doi.org/10.1158/1535-7163.MCT-11-0422
65. Tang JY, Xiao TZ, Oda Y, Chang KS, Shpall E, Wu A, et al. Vitamin 03 inhibits hedgehog signaling and proliferation in murine Basal cell carcinomas. Cancer Prev Res (Phila) 2011; 4:744-51. PMID:21436386; http://dx.doi.org/10.1158/1940-6207.CAPR-10-0285
66. Banerjee U, Ghosh M, Kyle Hadden M. Evaluation of vitamin 03 A-ring analogues as Hedgehog pathway inhibitors. Bioorg Med Chern Lett 2012; 22:1330-4. PMID:22226657; http://dx.doi.org/10.1016/j.bmcl.2011.12.081
67. Tang JY, So PL, Epstein EH Jr.. Novel Hedgehog pathway targets against basal cell carcinoma Toxicol Appl Pharmacol 2007; 224:257-64. PMID: 17276471; http://dx.doi.org/10.1016/j.taap.2006.12.011
68. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005; 16:83-95. PMID: 15868450; http://dx.doi.org/10.1007/sl0552-004-1661-4